全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

Seroprevalence of Hepatitis B Virus Infection (HBsAg) in Rural Blood Donors, Moba, Tanganyika Province, Democratic Republic of Congo (2014 to 2016)

DOI: 10.4236/oalib.1103434, PP. 1-5

Subject Areas: Hematology, Public Health

Keywords: Blood Donors, DRC, HBsAg, Hepatitis, Transfusion Safety

Full-Text   Cite this paper   Add to My Lib

Abstract

Blood transfusion is a salutary practice in modern medicine, but it carries a high risk of transmission of transfusion transmitted infections (TTIs), especially in developing countries. The objective of this study is to determine the seroprevalence of viral hepatitis B among blood donors. This is a retrospective and descriptive cross-sectional study of the period from 2014 to 2016 at the Katele Health Reference Center (Moba, DR. Congo). We investigated HBsAg in blood donors by using Determine HBSAg. 1145 blood donors with an age mean of 30.6 ± 6.9 years and predominantly male (62.5%) were retained. The seroprevalence of hepatitis B infection from 2014 to 2016 was 3.9% (0.3% for 2014, 9.4% for 2015 and 0.7% for 2016). The family blood donors (83.2%) were the only carriers of HBsAg and were significantly associated with hepatitis B infection (p < 0.05). Age [OR = 0.70 CI 95% 0.34-1.44; p 0.338] and sex [OR = 0.72 95% CI 0.27-1.97; p 0.529] were not associated with the occurrence of hepatitis B in blood donors. The risk of transmission of HBV during transfusion remains high. We recommend the strengthening of transfusion safety measures, the abandonment of family donors for regular voluntary donors, the improvement of screening and diagnostic tests, the involvement of the national blood transfusion program in epidemiological surveillance and the mobilization of the population in favor of the fight against hepatitis B.

Cite this paper

Kabemba, B. H. , Kasendue, E. P. , Shiku, M. A. , Mukena, T. S. , Kasolva, T. C. , Kabingie, N. G. , Pungue, K. J. and Kitengie, T. J. (2017). Seroprevalence of Hepatitis B Virus Infection (HBsAg) in Rural Blood Donors, Moba, Tanganyika Province, Democratic Republic of Congo (2014 to 2016). Open Access Library Journal, 4, e3434. doi: http://dx.doi.org/10.4236/oalib.1103434.

References

[1]  Giri Purushottam, A., Deshande Jayant, D., Phalke Deepak, B. and Karle Laximan, B. (2012) Seroprevalence of Transfusion Transmissible Infections among Voluntary Blood Donors at a Tertiary Care Teaching Hospital in Rural Area of India. Journal of Family Medicine and Primary Care, 1, 48-51.
https://doi.org/10.4103/2249-4863.94452
[2]  OMS (2016) Hepatitis B. Fact Sheet No. 204.
www.who.int/mediacentre/factsheets/fs204
www.who.int/mediacentre/factsheets/fs204/fr
[3]  Zhang, L., Jiao, S., Yang, Z., Xu, L., Liu, L., Feng, O., et al. (2016) Prevalence of Hepatitis E Virus Infections among Blood Donors in Mainland China: A Meta-Analysis. Transfusion, 57, 248-257.
https://doi.org/10.1111/trf.13937
[4]  Pozzeto, B. and Garraud, O. (2016) New Viral Risks in Blood Transfusion by 2016 [Nouveaux risques viraux en transfusion sanguine à l’horizon 2016]. Transfusion Clinique et Biologique, 23, 20-27.
https://doi.org/10.1016/j.tracli.2015.12.004
[5]  Kiire, C.F. (1996) The Epidemiology and Prophylaxis of Hepatitis B in Sub-Saharan Africa: A View from Tropical and Subtropical Africa. Gut, 38, S5-S12.
https://doi.org/10.1136/gut.38.suppl_2.s5
[6]  Michel, K.N., Pascal, K.M., Mariette, K.K., Blaise, I.K., Tonny, N.N., Ignace, B.K., et al. (2016) Seroprevalence Hepatitis B in Blood Donors at Lubumbashi, DR Congo (Case of Provincial Hospital Sendwe Reference). Open Access Library Journal, 3, e3105.
https://doi.org/10.4236/oalib.1103105
[7]  Batina Agasa, B., Gulbis, M., Dramaix, W. and Losimba Likwela, L. (2013) Evolution of Markers of Viral Infections Transmitted by Transfusion from 2005 to 2008 in Kisangani. Democratic Republic of Congo [évolution des marqueurs d’infections virales transmises par transfusion de 2005 à 2008 à Kisangani. République Démocratique du Congo]. Revue Médicale des Grands Lacs, 2, 283-292.
[8]  Diro, E., Alemu, S. and Gy, A. (2008) Blood Safety and Prevalence of Transfussion Transmissible Viral Infections among Donors at the Red Cross Blood Bank in Gondar University Hospital. Ethiopian Medical Journal, 46, 7-13.
[9]  World Health Organization. Global Database on Blood Safety: Report 2001-2002.
http://www.who.int/bloodsafety/GDBS_Report_2001-2002.pdf
[10]  Xie, D.-D., Li, J., Chen, J.-T., Eyi, U.M., Matesa, R.A., Obono, M.M.O., et al. (2015) Seroprevalence of Human Immunodeficiency Virus, Hepatitis B Virus, Hepatitis C Virus, and Treponema pallidum Infections among Blood Donors on Bioko Island, Equatorial Guinea. PLoS ONE, 10, e0139947.
https://doi.org/10.1371/journal.pone.0139947
[11]  Kabemba Bukasa, H., Kamuanya Wa Tshitanda, E., Kitengie Tshite, J., Atibu Bin Atibu, B., Ngiele Mposhi, D. and Pungue Kabiswe, J. (2017) Seroprevalence of Human Immunodeficiency Virus and Hepatitis B and C Infections in Blood Donors in the Security Transfusion Service Center of Kalemie (Democratic Republic of Congo) [Séroprévalence des infections par les virus de l’immunodéficience humaine et des hépatites B et C chez les donneurs de sang au service de sécurité transfusionnelle de Kalemie (République Démocratique du Congo)]. Médecine d’Afrique noire, 64, 47-56.
[12]  Belyhun, Y., Maier, M., Mulu, A., Diro, E. and Liebert Uwe, G. (2016) Hepatitis Virus in Ethiopia: A Systematic Review and Meta-Analysis. BMC Infectious, 16, 761
https://doi.org/10.1186/s12879-016-2090-1
[13]  Hamdoun Zahmoul, M. and Bahri, O. (2010) Assay of AgHBS: New Marker for the Monitoring of Chronic Viral Hepatitis B [Dosage de l’AgHBS: nouveau marqueur pour le suivi des Hépatites virales chroniques B]. Rev. Tunisienne dInfectiologie, 4, 117-121.
[14]  Rakotoniaina, A.I., Randriamanantany, Z.A., Ranaivosoa, K.H.M., Andriambelo, V., Fortune, H., Rakoto Alson, O.A., et al. (2013) Seroprevalence of HIV, HBV, HCV and Treponema pallidum in Voluntary Blood Donors at the National Blood Tran- sfusion Center in Antananarivo from 1992 to 2010 [Séroprévalence du VIH, VHB, VHC et de Treponema pallidum chez les donneurs du sang bénévoles au centre national de transfusion sanguine d’Antananarivo de 1992 à 2010]. Revue Medicale de Madagascar, 3, 264-268.
[15]  Hwang, E.W. and Cheung, R. (2011) Global Epidemiology of Hepatitis B Virus (HBV) Infection. North American Journal of Medical Sciences, 4, 7-13.
https://doi.org/10.7156/v4i1p007
[16]  Matee, M.I., Lyamuya, E.F., Mbena, E.C., Magessa, P.M., Sufi, J., Marwa, G.J., et al. (1999) Prevalence of Transfusion-Associated Viral Infectious and Syphilis among Blood Donors in Muhimbili Medical Centre, Dar es Salaam, Tanzania. East African Medical Journal, 76, 167-171.
[17]  Musa, B.M., Bussell, S., Borodo, M.M., Samaila, A.A. and Femi, O.L. (2015) Prevalence of Hepatitis B Virus Infection in Nigeria, 2000-2013: A Systematic Review and Meta-Analysis. Nigerian Journal of Clinical Practice, 18, 2, 163-172.
https://doi.org/10.4103/1119-3077.151035
[18]  Nwankwo, E., Momodu, I., Umar, I., Musa, B. and Adeleke, S. (2012) Seroprevalence of Major Blood-Borne Infections among Blood Donors in Kano, Nigeria. Turkish Journal of Medical Sciences, 42, 337-341.
[19]  Noah Noah, D., Njouom, R., Bonny, A., Pirsou, Meli, J. and Sida Biwole, M. (2011) HBs Antigen Prevalence in Blood Donors and the Risk of Transfusion of Hepatitis B at the Central Hospital of Yaounde, Cameroon. Open Journal of Gastroenterology, 1, 23-27.
https://doi.org/10.4236/ojgas.2011.12004
[20]  Tessema, B., Yismaw, G., Kassu, A., Amsalu, A., Mulu, A., Emmrich, F. and Sack, U. (2010) Seroprevalence of HIV, HBV, HCV and Syphilis Infections among Blood Donors at Gondar University Teaching Hospital, Northwest Ethiopia: Declining Trends over a Period of Five Years. BMC Infectious Diseases, 10, 111.
www.biomedcentral.com/1471-2334/10/111
https://doi.org/10.1186/1471-2334-10-111
[21]  Tagny, C.T., Owusu-Ofori, S., Mbanya, D. and Deneys, V. (2010) The Blood Donor in Sub-Saharan Africa: A Review. Transfusion Medicine, 20, 1-10.
https://doi.org/10.1111/j.1365-3148.2009.00958.x
[22]  Tiwari, B.R., Ghimire, P., Kanoul, S.R. and Rajkarnikar, M. (2010) Seroprevalence of HBV and HCV in Blood Donors: A Study from regional Blood Transfusion Services of Nepal. Asian Journal of Transfusion Science, 4, 91-93.
https://doi.org/10.4103/0973-6247.67026
[23]  Mavenyengwa, R.T., Munyaradzi, M., Chipare, I. and Shoombe, E. (2014) Prevalence of Human Immunodeficiency Virus, Syphilis, Hepatitis B and C in Blood Donations in Namibia. BMC Public Health, 14, 424.
https://doi.org/10.1186/1471-2458-14-424
[24]  Mbendi Nlombi, C., Longo-Mbenza, B., Mbendi Nsukini, S., Muyembe Tamfumu, J.J., Situa Kibanza, H. and Vangu Ngoma, D. (2001) Prevalence of HIV and HBS Antigen in Blood Donors, Residual Risk of Contamination in Recipients of Blood of East Kinshasa, Democratic Republic of Congo [Prévalence du VIH et de l’Antigène HBS chez les donneurs du sang, risque résiduel de contamination chez les receveurs du sang de Kinshasa-Est, République Démocratique du Congo]. Medecine Tropicale, 61, 139-1423.
[25]  Kakisingi Ngama, C., Mukuku, O., Matanda Kapend, S., Manika Muteya, M., Kyabu Kabila, V., Kasamba Ilunga, E., et al. (2016) Epidemiological Profile and Seroprevalence of Blood Donors at University Clinics in Lubumbashi, Democratic Republic of Congo [Profil épidémiologique et séroprévalence des donneurs de sang aux cliniques universitaires de Lubumbashi, République Démocratique du Congo]. Pan African Medical Journal, 23, 175.
http://www.panafrican-med-journal.com/content/article/23/175/full/
[26]  Batina, A., Kabemba, S. and Malengela, R. (2007) Infectious Markers in Blood Donors in the Democratic Republic of Congo (DRC) [Marqueurs infectieux chez les donneurs de sang en République Démocratique du Congo (RDC)]. Revue Médicale de Bruxelles, 28, 145-149.
[27]  Namululi, B.A., Guerrieri, C. and Dramaix, M. (2012) Impact of Blood Donor Recruitment on HIV and HBV Prevalence in Bukavu, Democratic Republic of Congo [Impact du mode de recrutement des donneurs de sang sur la prévalence du VIH et du VHB à Bukavu, République Démocratique du Congo]. Médecine et Santé Tropicales, 22, 69-74.
[28]  Kabamba Nzaji, M. and Kabyla Ilunga, B. (2013) Prevalence of Infectious Markers in Rural Blood Donors. Case of the General Hospital of Reference of Kamina [Prévalence des marqueurs infectieux chez les donneurs de sang en milieu rural. Cas de l’Hopital General de Reference de Kamina]. Santé Publique, 25, 213-217.
[29]  Jaroszewicz, J., Serrano, B.C., Wursthorn, K., Deterding, K., Schlue, S., Raupach, R., et al. (2010) Hepatitis B Surface Antigen (HBsAg) Levels in the Natural History of Hepatitis B Virus (HBV) Infection: A European Perspective. Journal of Hepatology, 52, 514-522.
https://doi.org/10.1016/j.jhep.2010.01.014
[30]  World Health Organization (1975) Resolution WHA28.72: Use and Production of Human Blood and Its Derivatives. 28th World Health Assembly, Geneva, 13-30 May 1975. [L’Assembléemondiale de la Santé (1975) Résolution WHA28.72: Utilisation et obtention du sang humain et de ses dérivés. Vingt-Huitième Assemblée mondiale de la Santé, Genève, 13-30 Mai 1975, Genève].
[31]  Determine HBSAg, Mars (2007) Inverness Medical Japan.
www.determinetest.com
[32]  Benjemiar, R. and Gouider, E. (2014) Seroprevalency of Transmission-Transmitted Infection in First-Time Volunteer and Replacement Donors in Tunisia. Transfusion Clinique et Biologique, 21, 303-308.
https://doi.org/10.1016/j.tracli.2014.10.001
[33]  Kabinda, J.M., Miyanga, S.A., Misingi, P. and Ramarani, S.Y. (2014) Hepatitis B and C in Unpaid Blood Donors in Eastern Democratic Republic of Congo [Les hépatites B et C chez les donneurs bénévoles de sang et non rémunérés à l’Est de la République Démocratique du Congo]. Transfusion Clinique et Biologique, 21, 111-115. https://doi.org/10.1016/j.tracli.2014.04.001
[34]  Kra, O., N’Dri, N., Ehui, E., Ouattara, B. and Bissagnene, E. (2007) Prevalence of HBS Antigen in Blood Donors and the Regional Blood Transfusion Center in Bouaké, Ivoire-coast, 2001 [Prévalence de l’Antigène HBS chez les donneurs de sang et au centre régional de transfusion sanguine de Bouaké Cote d’Ivoire en 2001]. Bulletin de la Société de Pathologie Exotique, 100, 127-129.
[35]  Portelinha Filho, A.M., Ulloffo, D.O., Naseimento, C., Nicastro Tannouri, T., Troiani, C., Lopes Ascencio, E., Bonfim, R., et al. (2009) Seroprevalence of HBV, HCV and HIV Co-Infection in Selected Individual from State of Sao Paulo, Brazil. Memórias do Instituto Oswaldo Cruz, 104, 960-963.
https://doi.org/10.1590/S0074-02762009000700003
[36]  Ehoussou, K., Tiembre, I., Benie, J., N’Doutable, M., Dagnan, S., Djeha, D., et al. (1997) Evaluation of Seroprevalence of HIV and HBV Infection among Military Blood Donors in Abidjan [Evaluation de la séroprévalence de l’infection à VIH et VHB chez les donneurs de sang militaires à Abidjan]. Médecine d’Afrique noire, 44, 620-624.
[37]  Shrestha, A.C., Ghimire, P., Tiwari, B.R. and Rajkarnikar, M. (2009) Transfusion-Transmissible Infectious among Blood Donors in Kothmandu, Nepal. Journal of Infection in Developing Countries, 3, 794-797.
[38]  Dray, X., Dray-Spira, R., Bronstein, J.A. and Mattera, D. (2005) Seroprevalence of Human Immunodeficiency Viruses and Hepatitis B and C among Blood Donors in the Republic of Djibouti [Séroprévalence des virus de l’immunodéficience humaine et des hépatites B et C parmi les donneurs de sang en République de Djibouti]. Medecine Tropicale, 65, 39-42.
[39]  WHO (2015) Transfusion Safety and Blood Supply, Fact Sheet No. 279 [OMS. Sécurité transfusionnelle et approvisionnement en sang, Aide-mémoire No. 279].
[40]  Pillonel, J., Saura, C. and Courouce, A.M. (1998) Prevalence of HIV, HTLV and Hepatitis B and C Viruses in Blood Donors in France [Prévalence du VIH, de l’ HTLV et des virus des hépatites B et C chez les donneurs de sang en France]. 1992-1996. Transfusion Clinique et Biologique, 5, 305-312.
https://doi.org/10.1016/S1246-7820(98)85001-5
[41]  Diarra, A., Kouriba, B., Baby, M., Murphy, E. and Lefrere, J.-J. (2009) HIV, HCV, HBV and Syphilis Rate of Positive Donations among Blood Donations in Mali: Lower Rates among Volunteer Blood Donors. Transfusion Clinique et Biologique, 16, 444-447.
https://doi.org/10.1016/j.tracli.2009.09.004
[42]  Noubiap, J.J., Joko, W.Y., Nansseu, J.R., Tene, U.G. and Siaka, C. (2013) Sero-Epidemiology of Human Immunodeficiency Virus, Hepatitis B and C Viruses, and Syphilis Infections among First-Time Blood Donors in Edéa, Cameroon. International Journal of Infectious Diseases, 17, 832-837.
https://doi.org/10.1016/j.ijid.2012.12.007
[43]  Hudu, S.A., Harmal, N.S., Saeed, M.I., Alshari, A.S., Malik, Y.A., Niazlin, M.T., et al. (2016) Molecular and Serological Detection of Occult Hepatitis B Virus among Healthy Hepatitis B Surface Antigen-Negative Blood Donors in Malaysia. African Health Sciences, 16, 677-683.
https://doi.org/10.4314/ahs.v16i3.6
[44]  Kabinda Maotela, J., Ramazani, S.Y., Misingi, P. and Dramaix-Wilme, M. (2015) Blood Transfusion in the Democratic Republic of Congo: Efforts and Challenges [Transfusion sanguine en République Démocratique du Congo: Efforts réalisés et défis à relever]. Médecine et Santé Tropicale, 25, 342-349.
[45]  Mecky, I.N.M., Pius, M.M. and Eligius, F.L. (2006) Seroprevalence of Human Immunodeficiency Virus, Hepatitis B and C Viruses and Syphilis Infections among Blood Donors at the Muhimbili National Hospital in Dar Es Salaam, Tanzania. BMC Public Health, 6, 21.
http://www.biomedcentral.com/1471-2458/6/21
https://doi.org/10.1186/1471-2458-6-21
[46]  O’Brien, S.F., Xi, G., Fan, W., Yi, Q.L., Fearon, M.A., Scalia, V., et al. (2008) Epidemiology of Hepatitis B in Canadian Blood Donors. Transfusion, 48, 2323-2330.
https://doi.org/10.1111/j.1537-2995.2008.01845.x
[47]  Farshadpour, F., Taherkhani, R., Tajbakhsh, S., Gholizadeh Tangestani, M., Hajiani, G., Sharifi, N., et al. (2016) Prevalence and Trends of Transfusion-Transmissible Viral Infections among Blood Donors in South of Iran: An Eleven-Year Retrospective Study. PLoS ONE, 11, e0157615.
https://doi.org/10.1371/journal.pone.0157615
[48]  Liu, G.-C., Sui, G.-Y., Liu, G.-Y., Zheng, Y., Deng, Y., Gao, Y.-Y., et al. (2013) A Bayesian Meta-Analysis on Prevalence of Hepatitis B Virus Infection among Chinese Volunteer Blood Donors. PLoS ONE, 8, e79203.
https://doi.org/10.1371/journal.pone.0079203
[49]  Gonzalez, M., Regine, V., Piccinini, V., Vulcano, F., Giampaolo, A. and Hassan, H.J. (2005) Residual Risk of Transfusion Transmitted Human Immunodeficiency Virus, Hepatitis C Virus, and Hepatitis B Virus Infections in Italy. Transfusion, 45, 1670-1675.
https://doi.org/10.1111/j.1537-2995.2005.00576.x
[50]  WHO (2010) Screening for Transmitted Diseases in Blood Transfusion: Recommendations [OMS, Dépistage des infections transmissibles par transfusion dans les dons de sang: Recommandations]. NLM-WB 356, Organisation mondiale de la Santé, 2-24.
[51]  Tafesse, T.B., Geru, A.A., Gobalee, S., Belly, G.D., Belew, M.T., Arso, D., et al. (2016) Seroprevalence and Diagnosis of HIV, HBV, HCV and Syphilis Infections among Blood Donors. Human Antibodies, 16, 1-17.
[52]  WHO and IFRC (2011) Towards 100% Voluntary Blood Donation, Global Framework for Action [OMS et FICR. Vers 100 % de dons de sang volontaire, Cadre mondial d’action]. NLH-WH 460, 6-25.
[53]  Njai, H.F., Shimakawa, Y., Sanneh, B., Ferguson, L., Ndow, G., Mendy, M., et al. (2015) Validation of Rapid Point-of-Care (POC) Tests for Detection of Hepatitis B Surface Antigen in Field and Laboratory Settings in the Gambia, Western Africa. Journal of Clinical Microbiology, 53, 1156-1163.
https://doi.org/10.1128/JCM.02980-14
[54]  Shivkumar, S., Peeling, R., Jafari, Y., Joseph, L. and Pai, N.P. (2012) Rapid Point-of-Care First-Line Screening Tests for Hepatitis B Infection: A Metaanalysis of Diagnostic Accuracy (1980-2010). American Journal of Gastroenterology, 107, 1306-1313.
https://doi.org/10.1038/ajg.2012.141
[55]  Rajaonatahina, D.H., Randriamanantany, Z.A., Rakotomalala, R., Andriamahenina, R., Contamin, B., Alson, R., et al. (2011) Evaluation of Rapid Tests for the Detection of HBsAg in the Immunology Laboratory CHUA-JRA Ampefiloha, Antananarivo, Mada-gascar [Evaluation des tests rapides pour le dépistage de l’AgHBs au laboratoire d’Immunologie CHUA-JRA Ampefiloha, Antananarivo, Madagascar]. Revue Medicale de Madagascar, 1, 20-23.
[56]  Bhattacharya, P., Chandra, P.K., Dattas, S., Banerjee, A., Chakraborty, S., Rajen- dran, K., et al. (2007) Significant Increase in HBV, HCV, HIV and Syphilis Infectious among Bloods Donors in West Bengal, Eastern Indian 2004-2005: Exploratory Screening Reveals High Frequency of Occult HBV Infection. World Journal of Gastroenterology, 13, 3730-3733.
https://doi.org/10.3748/wjg.v13.i27.3730
[57]  Poveda, J.-D. (2008) Screening and Biological Monitoring, Contributions of Molecular Biology Techniques [Hépatites Virales B: Dépistage et suivi biologique, Apports des techniques de biologie moléculaire]. Laboratoire Pasteur Cerba, Tunis.
[58]  World Health Organization (WHO) (2004) Laboratory Biosafety Manual. 3rd Edition, World Health Organization, Geneva.
[59]  National Institute of Public Health of Quebec (2016) Recommended Laboratory Tests for Screening for Hepatitis B Virus, Government of Québec [Institut national de santé publique du Québec (2016) Analyses de laboratoire recommandées pour le dépistage de l’infection par le virus de l’hépatite B, Gouvernement du Québec].
http://www.inspq.qc.ca
[60]  Assal, A., Barlet, V., Deschaseaux, M., Dupont, I., Gallian, P., Guitton, C., et al. (2009) Sensitivity of Two Hepatitis B Virus, Hepatitis C Virus (HCV), and Human Immunodeficiency Virus (HIV) Nucleic Acid Test Systems Relative to Hepatitis B Surface Antigen, Anti-HCV, Anti-HIV, and p24/Anti-HIV Combination Assays in Seroconversion Panels. Transfusion, 49, 301-310.
https://doi.org/10.1111/j.1537-2995.2008.01966.x
[61]  Blanco, S., Balangers, M.C., Valle, M.C., Montini, O.L., Carrizo, L.H. and Gallego, S.V. (2016) Usefulness of Nucleic Acid Testing of Reduces Risk of Hepatitis B Virus Transfusion-Transmitted Infection in Argentina: High Rate of Recent Infections. Transfusion, Epub.

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413